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BACKGROUND: The processes of malignant tumour invasion and metastasis are known to include
the destruction of cell stroma and vascular basement membrane. It has been suggested that type IV
collagenase degrades type IV collagen, a main component of the basement membrane.
METHODS: In our study, type IV collagenase activity in human thyroid tumours was measured by
the Liotta method. The degree of destruction of diseased regions of thyroid tumours was immunohis-
tochemically determined by anti-type IV collagen antibody staining. Cell proliferation in the tumours
was estimated using anti-proliferating cell nuclear antigen (PCNA) and epidermal growth factor
receptor (EGFR).
RESULTS: T4 thyroid carcinomas with higher type IV collagenase activity and very weak type IV
discontinuous immunostaining for type IV collagen of follicular basement membranes, exhibited many
PCNA or EGFR positive cells. In benign tumours, normofollicular- or macrofollicular-type tumours with
low type IV collagenase activity showed few PCNA and EGFR positive cells and intact type IV collagen
of basement membranes, as seen in normal thyroids. Conversely, an atypical adenoma with higher type
IV collagenase activity showed many PCNA and EGFR positive cells and weak type IV discontinuous
immunostaining for type IV collagen, as in thyroid carcinomas.
CONCLUSION: These findings suggest that staining for type IV collagen and type IV collagenase
activity reflect the ability of cell proliferation, and help predict the aggressiveness of invasion and
metastasis in human thyroid tumours. (Asian J Surg 2002;25(4):304–8)
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INTRODUCTION
Tumour cell proliferation is required for the extension
of malignant tumours, invasion into the surrounding
tissues and metastasis.1 Ozzello reported that
morphological changes of basement membranes allow
tumours to invade.2 Fessler et al reported that progressive
malignant tumours have high levels of enzymes that
degrade type IV collagen, a main component of base-
ment membranes.3 Nonetheless, there have been no
reports regarding either type IV collagenase or its rela-
tionship to destructive grades of type IV collagen in
thyroid tumours. Understanding of the processes of inva-
sion and metastasis by thyroid tumours requires meas-
urement of their type IV collagenase activity. In our study,
type IV collagenase activity was measured in normal and
diseased thyroid tissues. The grade of destruction was
immunohistochemically determined by anti-type IV
collagen antibody staining. Cell proliferating ability of
thyroid tumours was immunohistochemically estimated
Asian Journal of Surgery 305
TYPE IV COLLAGEN IN HUMAN THYROID TUMOURS
by anti-proliferating cell nuclear antigen (PCNA) and
epidermal growth factor receptor (EGFR) antibodies. The
results were compared with extracapsular invasion, meta-
static potential and ability of cell proliferation in the same
tumours.
MATERIALS AND METHODS
Human thyroid tissues evaluated in this study were
surgically obtained from four patients with follicular
adenoma, six with papillary carcinoma and six with
follicular carcinoma. Normal thyroid tissues were fully
separated from the tumour in each of the six follicular
adenomas. Histopathological examination confirmed the
presence of normal or diseased thyroid tissue. Surgically
obtained specimens were stored at –80˚C until use.
Preparation of specimens
Frozen specimens were thawed by the addition of a
10-fold volume of 50 mM phosphate-buffered saline
(PBS) and then homogenized using a homogenizer
(Omega, Tokyo, Japan) at 1,300 rpm with stroking five
times. The homogenates were centrifuged at 700 x g for
15 minutes, and the supernatants were examined. Total
protein concentrations were measured with BCA Protein
Assay Reagent (Pierce, Rockford, USA).4
Type IV collagenase activity assay
Type IV collagenase activity was measured using the
Liotta method.5 Type IV collagen substrates were
composed of 50-µl portions of 0.2%[3H] type IV collagen
to which had been added 50 µL of 50 mM Tris buffer.
Then, 5 µL aliquots of the sample were diluted with
155 µL of 50 mM Tris buffer and preincubated for 10 min
at 37.0˚C with 40µL of 100 µg/ml trypsin to activate
any latent collagenase. The reaction with trypsin was
terminated by the addition of 40 µL of 500 µg/ml soybean
oil (Sigma, St. Louis, USA) at 37.0˚C for 10 min. Then a
160 µL aliquot of type IV collagen substrate was mixed
with a 240 µl portion of pre-incubated sample and incu-
bated at 37.0˚C for 24 hours. Following incubation, the
reaction mixture was made to final concentrations of 2%
CCl3COOH and 0.5% tannic acid was added to stop the
reaction. The mixture was then held on ice for 30 minutes.
The reaction tubes were centrifuged at 8,900 x g for
10 minutes at room temperature, and then 10 µL aliquots
of supernatant were counted in liquid scintillation cocktails
with 5 ml of Atomlight Gröningen, Holland). Type IV
collagenase activity was measured as the amount of
collagen degraded in the reaction tube over a 24 hour
period at 37.0˚C per 1mg of protein in the homogenate
(µg collagen/24h/mg protein).
Immunostaining of type IV collagen,
PCNA and EGFR
Portions of surgical materials were fixed in 10%
buffered formalin, and then paraffin sections were cut.
These sections were reacted with anti-type IV collagen
antibody (Dakopatts, Glostrup, Denmark), anti-PCNA
antibody (Coulter clone, Marseille, France) and anti-
EGFR antibody (Cambridge Research, Cambridge, UK).
The avidin-biotin peroxidase complex method was used
to visualize the binding of anti-type IV collagen, PCNA
and EGFR antibodies. Assay results for continuity of type
IV collagen on basement membranes of follicular cells
were classified as follows: intact type IV collagen was
graded +, weak immunostaining as +/–, and very weak
discontinuous immunostaining as –. We had an internal
control on each carcinoma sample: positive staining of
type IV collagen on normal or intact thyroid tissues
remote from carcinoma lesions. Results were obtained
from comparison between the internal positive control
(1+) and staining intensity of the diseased area in the
same carcinoma sample. On PCNA and EGFR staining,
many positive cells (10% over labelling index) were
graded + , and a few positive cells  (10% under labelling
index) as –.
RESULTS
The Table shows the continuity of type IV collagen in
basement membranes and type IV collagenase activity
for each case. Immunostaining of type IV collagen in
almost all normal thyroid tissue resulted in positive
reactions. On PCNA and EGFR staining, all normal cases
showed a few positive cells (Figure 1). Mean activities of
type IV collagenase in the normal thyroid groups were
0.280 µg collagen degraded/mg protein. These activities
were lower than in the tumour groups. In papillary
carcinomas, cases with extracapsular invasion (T4)
exhibited very weak discontinuous staining for type IV
collagen, and there was no staining in regions of invasion
of vascular basement membranes. Papillary carcinoma
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cases with T4 showed many PCNA and EGFR positive
cells. One papillary carcinoma (T1) without extracapsular
invasion exhibited weak staining for type IV collagen
overall, but the defect in staining for type IV collagen was
less than that of T4 disease.
The mean activity of type IV collagenase in papillary
carcinomas (1.003 µg collagen degraded/mg protein)
was significantly higher than that in normal thyroids,
follicular adenomas and follicular carcinomas (Mann-
Whitney U test, p < 0.05). The type IV collagenase
activity of one case of T1 (0.600 µg collagen degraded/
mg protein) was the lowest in the group with papillary
carcinoma, and follicular basement membranes had
intact type IV collagen. T4 follicular carcinoma exhibited
very weak discontinuity of type IV collagen overall and
showed many PCNA or EGFR positive cells, as seen in T4
papillary carcinoma (Figure 2). A T1 case and a T2 case
in the follicular carcinoma group without extracapsular
invasion exhibited weak staining for type IV collagen in
diseased regions overall, but the defect in staining was
less remarkable than for T4 disease. The type IV colla-
genase activities of T1 and T2 cases (0.254, 0.282 µg
collagen degraded/mg protein, respectively) were lower
than the mean of the follicular carcinoma group (0.493
µg collagen degraded/mg protein). Three follicular
adenomas exhibited weak staining for type IV collagen,
but less remarkable defects of staining than in T4 cases.
Benign tumours (normofollicular or macrofollicular
type) with low type IV collagenase activity showed few
PCNA or EGFR positive cells and type IV collagen of
basement membranes was intact. A benign tumour
(atypical adenoma) with higher type IV collagenase
activity exhibited many PCNA or EGFR positive cells, as
seen in thyroid carcinomas (Figure 3).
Table. Type IV collagenase activity and immunostaining of type IV collagen, proliferating cell nuclear antigen (PCNA)
and epidermal growth factor receptor (EGFR)
Histological No. of Type IV collagenase activity Immunostaining
diagnosis cases µg collagen degraded/mg protein
mean ± SD Type IV collagen PCNA EGFR
Normal thyroid 6 0.280 ± 0.076  + – –
Follicular adenoma 4 0.414 ± 0.137 +; ±  –; + –; +
Papillary carcinoma 6 1.003 ± 0.357 –; ± + +
Follicular carcinoma 4 0.493 ± 0.233 –; ± + +
Immunostaining for type IV collagen: + = intact type IV collagen; ± = weak immunostaining; – = very weak discontinuous
immunostaining overall. Immunostaining for PCNA and EGFR: + = many positive cells; – = few positive cells.
Figure 1. Normal thyroid
tissue with low activity of type
IV collagenase, stained for type
IV collagen (left) in the delinea-
tion of basement membrane,
and almost negative for both
PCNA (middle) and EGFR (right).
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DISCUSSION
Burtin et al reported that basement membranes of
colonic adenocarcinoma exhibit disappearance or
discontinuity of immunostaining for type IV collagen.6
Liotta reported that normal epithelial cells and benign
tumours could repair basement membranes, but
that malignant tumours could not.7 In the present study,
both benign and malignant thyroid tumours had
regions of little type IV collagen. T4 cases clearly had
larger staining defects than follicular adenomas. These
findings are similar to those reported by several other
investigators.
Cancer cells have been reported to exhibit low
adherence,8 particularly, poorly differentiated thyroid
tumours. Thyroid tumours were thought to survive in
spite of weak and defective type IV collagen. These
findings are  significant in the study of the first steps of
invasion and metastasis.9
Epithelial cells have been reported to synthesize type
IV collagens.10 Our study suggested that cancer cells lack
Figure 2. Follicular carci-
noma tissue with high activity
of type IV collagenase, showing
disappearance of type IV
collagen (left) in basement
membrane, and many PCNA
(middle) and EGFR (right)
positive cells.
Figure 3. An atypical ad-
enoma with high type IV colla-
genase activity, showing discon-
tinuity of type IV collagen (left)
in basement membrane, and
many PCNA (middle) and EGFR
(right) positive cells, as seen in
carcinoma.
type IV collagen due to diminished synthesis. Some
tumours with marked defects in type IV collagen had
higher activity of type IV collagenase than did tissue with
weak type IV collagen staining. This finding suggests that
the lower amounts of type IV collagen in thyroid tumours
may be related to the disturbance of collagen synthesis as
well as self-digestion by type IV collagenase. This sup-
ports the hypothesis that type IV collagenase is produced
in higher amounts in malignant tumours than in benign
diseases.
Previously, we reported that both PCNA and EGFR
can be used to evaluate proliferating ability in thyroid
diseases.11 T4 cases in thyroid carcinomas have higher
type IV collagenase activity and very weak type IV
discontinuity on immunostaining for type IV collagen.
They exhibited large numbers of PCNA and EGFR positive
cells. Benign tumours (normofollicular or macrofollicular)
had low type IV collagenase activity and few PCNA and
EGFR positive cells and intact type IV collagen in their
basement membranes. In contrast, an atypical adenoma
with higher type IV collagenase activity showed many
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PCNA and EGFR positive cells and weak discontinuity of
type IV collagen on immunostaining.
Our findings suggest that staining for type IV collagen
and type IV collagenase activity reflects the ability of
thyroid tumours to undergo cell proliferation and helps
predict their aggressiveness of invasion and propensity
for metastasis.
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